<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The Epstein-Barr virus (EBV) mutant P3HR1 is incapable of immortalizing B lymphocytes because of a 6.8-kilobase deletion in the BamHI W, Y, and H regions of the <z:mp ids='MP_0001799'>viral</z:mp> genome (M </plain></SENT>
<SENT sid="1" pm="."><plain>Rabson, L </plain></SENT>
<SENT sid="2" pm="."><plain>Gradoville, L </plain></SENT>
<SENT sid="3" pm="."><plain>Heston, and G </plain></SENT>
<SENT sid="4" pm="."><plain>Miller, J </plain></SENT>
<SENT sid="5" pm="."><plain>Virol </plain></SENT>
<SENT sid="6" pm="."><plain>44:834-844, 1982) </plain></SENT>
<SENT sid="7" pm="."><plain>To characterize transcripts that are encoded in this region, poly(A)+ <z:chebi fb="40" ids="33697">RNA</z:chebi> from the EBV-transformed lymphoblastoid cell line JY was isolated, and this <z:chebi fb="40" ids="33697">RNA</z:chebi> was used to generate a cDNA library in lambda gt10 </plain></SENT>
<SENT sid="8" pm="."><plain>By screening 500,000 recombinant bacteriophages with the BamHI H fragment, we isolated 10 cDNA clones and characterized them in detail </plain></SENT>
<SENT sid="9" pm="."><plain>One group of six cDNA clones was derived from a 2.9-kilobase early transcript encoded by the IR2 repeat element and showed restriction site polymorphism for the enzyme SmaI </plain></SENT>
<SENT sid="10" pm="."><plain>The second group consisted of four cDNA clones, <z:hpo ids='HP_0000001'>all</z:hpo> of which contained the BamHI-H right reading frame (BHRF1), and used the polyadenylation signal at base pair 662 in the BamHI F fragment </plain></SENT>
<SENT sid="11" pm="."><plain>Computer analysis of the hydrophobicity of the BHRF1 protein revealed that it is likely to be a membrane protein </plain></SENT>
<SENT sid="12" pm="."><plain>Northern blotting experiments with <z:chebi fb="40" ids="33697">RNA</z:chebi> from an EBV producer line, B95-8, and a tightly latent lymphoblastoid B-cell line, IB4, revealed that BHRF1 is contained in at least two different <z:chebi fb="2" ids="33699">mRNA</z:chebi> species which can be detected during the latent cycle of EBV </plain></SENT>
<SENT sid="13" pm="."><plain>These data and the recent characterization of a spliced transcript (containing five exons in common with other known latent messages [M </plain></SENT>
<SENT sid="14" pm="."><plain>Bodescot and M </plain></SENT>
<SENT sid="15" pm="."><plain>Perricaudet, Nucleic Acids Res </plain></SENT>
<SENT sid="16" pm="."><plain>14:7103-7113, 1986]) suggest that alternative splicing is used to generate transcripts containing BHRF1, as for the EBV nuclear antigen 1 transcripts </plain></SENT>
<SENT sid="17" pm="."><plain>Furthermore, the observation that a potential oncogene activated in human follicular <z:hpo ids='HP_0002665'>lymphomas</z:hpo> is homologous to the BHRF1-encoded <z:chebi fb="1" ids="15841">polypeptide</z:chebi> (M </plain></SENT>
<SENT sid="18" pm="."><plain>L </plain></SENT>
<SENT sid="19" pm="."><plain>Cleary, S.D </plain></SENT>
<SENT sid="20" pm="."><plain>Smith, and J </plain></SENT>
<SENT sid="21" pm="."><plain>Sklar, Cell 47:19-28, 1986) suggests a possible role for this putative <z:mp ids='MP_0001799'>viral</z:mp> protein in EBV-induced growth transformation of B lymphocytes </plain></SENT>
</text></document>